Latest Breaking News On - Global blood therapeutics - Page 8 : comparemela.com

UCB departs biotech trade group BIO

UCB left the biotech industry group BIO at the end of 2023, the second major member company to exit after Pfizer pulled out.

United statesErica puntelGlobal blood therapeuticsChair ted love

Pfizer Stock: High Dividend Yield, JN 1 Variant, And Therapeutic Innovations (PFE)

Pfizer Stock: High Dividend Yield, JN 1 Variant, And Therapeutic Innovations (PFE)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesNovo nordisk norditropinEli lilly verzenioMerck keytrudaArena pharmaceuticalsBiohaven pharmaceuticalsPfizer near term launchesHigh value pipelineWorld is gainingBristol myers squibbNovo nordiskSeeking alphaGlobal blood therapeuticsNovarti kisqaliEli lillyInflation reduction act

Patients with sickle cell disease using disease-modifying therapies more, but not enough

Patients with sickle cell disease using disease-modifying therapies more, but not enough
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesByjosh friedmanMindy valcarcelUniversity of pittsburgh school pharmacyGlobal blood therapeuticsVictoria newmanClinformatics data mart database

Factbox-How Pfizer is fortifying for growth beyond COVID products

The company on Wednesday forecast revenue from its COVID-19 vaccine and treatment to be $8 billion in 2024, a far cry from the $57 billion in 2022. In March, Pfizer announced a $43 billion acquisition of drugmaker Seagen to bring into its fold four approved cancer therapies. Last year, the company struck an $11.6 billion deal for migraine drug maker Biohaven Pharmaceutical Holding and bought Global Blood Therapeutics for $5.4 billion, adding sickle cell disease treatment Oxbryta to its pipeline.

United statesKhushi mandowaraSriraj kalluvilaManas mishraDamien conoverCaribou sciencesBiohaven pharmaceutical holdingGlobal blood therapeuticsAkero therapeuticsUnited kingdomGlobal blood therapeuticsBiohaven pharmaceutical holdingBiohaven pharmaceuticalCost cuttingAribou sciences and akero therapeutics

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSaint patrickNew yorkerKevin daviesVerne masonLinus paulingVernon ingramEdward jennerJames herrickEmily whiteheadJennifer doudnaLouise brownJohns hopkinsAnthony allisonPatrick mcgann